Medipharcon GmbH & Co. KG was founded in 2015 as a broker for finished medicinal products and active pharmaceutical ingredients (APIs) according to § 67 (1) AMG (German drug law).

After an inspection by the responsible Hamburg authority for health and consumer protection (BVG), Department of Pharmaceuticals and Medical Devices at the end of January 2020, Medipharcon GmbH & Co. KG is registered as  dealer for the license-free drug trade and has access to classic herbal raw materials as well as raw materials of traditional Chinese medicine (TCM) through cooperation partners in China.

 

In 2018, it was able to establish a strategic cooperation with Guizhou Zhongde Shengze Fakang Pharmaceutical Technology Co. Ltd. to define and jointly pursue a number of different projects in the healthcare segment.

 

This partnership was confirmed at the beginning of 2019 by the entry of Guizhou Shenghenkangze International Medicinal Technology Co. Ltd. as a limited partner into the company Medipharcon GmbH & Co. KG.

 

Both companies work closely with Guizhou DaLong Pharmaceutical Co. Ltd. (www.dlyy888.com). Founded in 1994, Guizhou DaLong Pharmaceutical Co., Ltd. is a successful owner-managed pharmaceutical company represented in the Chinese market with several phytopharmaceuticals.

 

Through excellent contacts to different decision-makers in the Chinese market, we are able to provide interested companies in the healthcare industry with appropriate contacts to potential cooperation partners in China.

 

In this context, we would like to welcome cooperation ideas from companies that would like to accompany us on this exciting journey to the most promising market in the world, also in the healthcare industry !

Download
Medipharcon_EudraGMDP.pdf
Adobe Acrobat Dokument 40.3 KB